February 2024

Episode 4 of the Team Heather podcast, hosted by The Heather Cutler Foundation, titled "February 2024" was published on December 1, 2024 and runs 23 minutes.

December 1, 2024 ·23m · Team Heather

0:00 / 0:00

Summary

In an effort to bring Heather’s story to life and provide a more vivid understanding of the challenges faced by pancreatic cancer patients, we’ve included original audio from her medical appointments. These recordings capture the raw, unfiltered reality of navigating a healthcare system that often leaves patients in smaller provinces feeling overlooked and unsupported. From discussions about treatment options to the absence of precision medicine-focused clinical trials in Newfoundland, the audio highlights systemic barriers that many patients face—barriers that directly impact survival outcomes and quality of life. By sharing these deeply personal moments, we aim to illustrate the human cost of inequitable healthcare access and advocate for urgent change. Heather’s journey is not just her own; it represents the struggle of countless Canadians who deserve better. This episode is a call to action, demanding equity in healthcare resources, clinical trial availability, and access to cutting-edge treatments for all, regardless of postal code.

Episode Description

These recordings capture the raw, unfiltered reality of navigating a healthcare system that often leaves patients in smaller provinces feeling overlooked and unsupported. From discussions about treatment options to the absence of precision medicine-focused clinical trials in Newfoundland, the audio highlights systemic barriers that many patients face—barriers that directly impact survival outcomes and quality of life.

By sharing these deeply personal moments, we aim to illustrate the human cost of inequitable healthcare access and advocate for urgent change. Heather’s journey is not just her own; it represents the struggle of countless Canadians who deserve better.

This episode is a call to action, demanding equity in healthcare resources, clinical trial availability, and access to cutting-edge treatments for all, regardless of postal code.